Pharmacokinetics and systemic effects of inhaled fluticasone propionate in healthy subjects

Abstract

To conclude, a slow elimination of FP leads to accumulation during repeated dosing. This accumulation may explain the marked decrease in plasma cortisol seen during treatment with fluticasone propionate within the clinical dose range.